| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Amylase Activity and Gut Contraction
Division of Molecular Science (T.S., M.T.), Graduate School of Science and Technology, Kobe University, Nada, Kobe 657-8501, Japan; and Suntory Institute for Bioorganic Research (H.S., H.M.), Shimamoto, Mishima, Osaka 618-8503, Japan
Address all correspondence and requests for reprints to: Makio Takeda, Ph.D., Division of Molecular Science, Graduate School of Science and Technology, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Japan. E-mail: mtakeda{at}kobe-u.ac.jp.
| Abstract |
|---|
|
|
|---|
-amylase activity was observed upon addition of CCAP to the midgut. These results suggest that CCAP is involved in digestion of carbohydrate in a paracrine manner. In situ hybridization and immunohistochemistry also revealed CCAP expression in the cell bodies of the ingluvial ganglion, which innervates the midgut muscle layer but not the epithelium, indicating that CCAP is produced in the ingluvial ganglion and then transported to the muscle layer through nerve fibers. Furthermore, CCAP was found to stimulate the contraction of the foregut, midgut, and hindgut in a dose-dependent manner. Taken together, our data indicate the multifunctionality of CCAP in the regulation of gut tissues as both a neuropeptide and a novel midgut factor. | Introduction |
|---|
|
|
|---|
In insects, the midgut is the primary tissue for digestion and absorption of nutrients. The stomatogastric nervous system, which consists of a nerve trunk along the dorsal surface of the foregut, and the proctodeal nervous system, which originates from the terminal ganglion of the ventral nerve cord, innervate the midgut (2). These nervous systems innervate only the midgut musculature, indicating that the digestive and absorptive cells in the midgut epithelium are not regulated by nerve tissues (3). Thus, nonneural regulatory mechanisms are expected to regulate digestion and absorption in insect midgut (4). Apart from the visceral nervous system, the insect midgut epithelium contains secretory cells called endocrine cells or midgut paraneurons (5). Ultrastructural studies have detected exocytosis of secretory granules from insect midgut endocrine cells that have morphological similarity to vertebrate gut endocrine cells (6). Immunohistochemical observations using antibodies against mammalian neuropeptides also support the presence of diverse neuropeptide-like compounds in midgut endocrine cells (7, 8). To date, gene expression of insect neuropeptides such as allatostatin, leucomyosuppressin, and neuropeptide F have been detected in the midgut endocrine cells of insects (9, 10, 11), which is consistent with the physiological role of midgut endocrine cells as a major source of gut neuropeptides. However, molecular and/or functional aspects of midgut neuropeptides have not been well characterized.
The exceptional omnivorous property of cockroaches in the insect kingdom allows us to presume that the cockroach midgut is conferred with not only a highly advanced digestive system, but also multiple gut-peptidergic regulatory mechanisms. We have been studying the functions of neuropeptides in the cockroach midgut. In this article, we describe the bioactivity of an arthropod neuropeptide, crustacean cardioactive peptide (CCAP), the CCAP cDNA sequence, and the tissue-distribution of CCAP peptide and mRNA, providing evidence that CCAP serves as a novel multifunctional midgut factor as well as a neuropeptide.
| Materials and Methods |
|---|
|
|
|---|
Extraction of peptides from the midgut
The midguts of P. americana were dissected from 1650 adults and placed immediately into PBS [0.01 M phosphate buffer (pH 7.4), 0.9% NaCl] after luminal food stuffs had been removed. The isolated organs were immediately frozen on dry ice and stored at 80 C. The pooled tissues, which weighed 34.3 g, were boiled for 10 min in 5 vol of water. After cooling, acetic acid was added to a final concentration of 4%. The tissues were homogenized at ice-cold temperature using a Polytron, and then centrifuged at 15,000 x g for 20 min at 4 C. The supernatant was chromatographed using C18 cartridges (Mega Bond Elut C18, Varian, Harbor, CA). After washing each cartridge with 0.1% trifluoroacetic acid (TFA), the retained material was eluted with 60% acetonitrile in 0.1% TFA. The eluate was concentrated to a small volume in a centrifugal vacuum-evaporator (CE 1, Hitachi Koki Co., Ltd., Tokyo, Japan).
HPLC purification and sequencing of peptide
The concentrated material was filtered through a 0.45-µm membrane filter (Chromatodisk 4N, Kurabo, Tokyo, Japan), applied to a reversed-phase HPLC (RP-HPLC) column (Capcell Pak C18, 10 x 250 mm, Shiseido, Tokyo, Japan), and eluted with a 70-min linear gradient of 070% acetonitrile in 0.1% TFA at a flow rate of 1.0 ml/min at 40 C. Column effluent was monitored spectrophotometrically at 220 nm. Forty fractions of 2 ml each were collected and 1/1000 of each fraction was assayed for myomodulatory activity using the foregut of the cricket as previously described (12). Myostimulatory fractions were pooled, reduced in volume using a centrifugal-vacuum evaporator, and applied to a cation-exchange column (TSKgel SP-5PW, 4.6 x 150 mm, Tosoh, Tokyo, Japan). A 00.6 M gradient of NaCl in 10 mM phosphate buffer (pH 6.7) was applied to the top of the column over 90 min at a flow rate of 0.5 ml/min at 40 C. Positive fractions were purified by alternating RP-HPLC separations and the assay to produce a single UV-absorbance peak. The amino acid sequence of the purified peptide was determined by an automatic peptide sequencer (PSQ-1, Shimadzu, Kyoto, Japan).
Total RNA preparation
Frozen ventral nerve cords of the cockroaches (1 g) were pulverized by grinding under liquid nitrogen. Total RNA was extracted from the ground tissue using RNeasy mini kit (QIAGEN, Valencia, CA), according to the manufacturers instructions.
Amplification of the partial fragment of CCAP cDNA
All nucleotides were ordered from QIAGEN Japan (Tokyo, Japan) and Kiko-tech (Osaka, Japan), and all RT-PCRs and rapid amplifications of cDNA ends (RACE) were performed using Taq Ex polymerase (Takara, Kyoto, Japan) or rTaq DNA polymerase (Toyobo, Osaka, Japan), and 0.2 mM deoxynucleotide triphosphate on a thermal cycler (model GeneAmp PCR system 9600; PE Biosystems, Foster City, CA). First-strand cDNA was synthesized with the oligo[deoxythymidine (dT)]-anchor primer supplied in the 5'/3' RACE kit (Roche Diagnostics, Basel, Switzerland) and amplified with the anchor primer (Roche Diagnostics) and the first degenerate primers 5'-CCITT(T/C)TG(T/C)AA(T/C)GCITT(T/C)AC-3' (I represents an inosine residue), corresponding to the amino acid sequence PFCNAFT. These PCR experiments were performed using five cycles each consisting of 94 C for 30 sec, 40 C for 30 sec, and 72 C for 3 min, followed by 35 cycles each consisting of 94 C for 15 sec, 50 C for 30 sec, and 72 C for 3 min. The first-round PCR products were reamplified using the anchor primer and the degenerate primers 5'-AA(T/C)GCITT(T/C)ACIGGITG(T/C)GG-3', corresponding to the sequences NAFTGCG, where the last G was regarded as a C-terminal amidation signal. PCR was performed using five cycles of 94 C for 30 sec, 37 C for 1 min, and 72 C for 2 min, followed by 15 cycles of 94 C for 30 sec, 45 C for 30 sec, and 72 C for 2 min, and a final extension at 72 C for 10 min. The resulting PCR product was purified using the Qiaquick Gel Extraction kit (QIAGEN) and subcloned into the pCR II-TOPO vector using a TA cloning kit (Invitrogen Life Technologies, San Diego, CA) according to the manufacturers instructions. The DNA inserts of the positive clones were amplified by PCR with universal M13 primers.
Determination of the 5'-end sequence of CCAP precursor cDNA
Template cDNA was synthesized with an oligonucleotide primer complementary to nucleotides 595615 (5'-GGCTCCAGGGCTTCGTGATC-3'), followed by deoxy-ATP-tailing of the cDNA with deoxy-ATP and terminal transferase (Roche Diagnostics). The tailed cDNA was amplified with the oligo(dT)-anchor primer (Roche Diagnostics) and gene-specific primer 1 (5'-CTCCTGGAGTTGAGATGTGG-3', complementary to nucleotides 572592). This was followed by further amplification of the first-round PCR products with the anchor primer (Roche Molecular Biochemicals) and gene-specific primer 2 (5'-CTGCAAATCTC TTCCTCCGG-3', complementary to nucleotides 508527). Both first-round and second-round PCR steps were performed for 30 cycles of 30 sec at 94 C, 30 sec at 55 C, and 1.5 min at 72 C. The second-round PCR products were subcloned and the inserts were amplified as described above.
DNA sequencing
All nucleotide sequences were determined with Big-Dye sequencing kits (PE Biosystems) and an ABI PRISM TM 310 Genetic analyzer (PE Biosystems), and then analyzed with DNASIS-MAC software (Hitachi Software Engineering, Kanagawa, Japan). Universal M13 primers or gene-specific primers were used to sequence both strands.
RT-PCR
RT-PCR was performed on tissue samples of the brain, ventral nerve cord, foregut, midgut, hindgut, and Malpighian tubules of the cockroach. Total RNA was extracted from the tissues as described above and then spectrophotometrically quantified. First strand cDNA was synthesized in a 20-µl reaction volume with 2 µg of total RNA, using oligo(dT) primer and reverse transcriptase (Takara). Three microliters of the RT product was used for PCR. Amplification of CCAP precursor transcripts was conducted using specific primers for CCAP (forward primer, 5'-TAGGATGTTCTCTCGCTATCC-3'; reverse primer, 5'-GGCTGTCTTACAATTCTCCAG-3'). Then, PCR products were separated on 1.5% agarose gel and stained with ethidium bromide.
In situ hybridization
The midgut was dissected from a male cockroach and incubated in 4% paraformaldehyde/PBS at 4 C overnight. After washes with PBS to remove the fixative, the fixed midgut was dehydrated in ethanol and xylene and embedded in paraffin. Serial sections with 7 µm thickness were made and treated as previously described (13). Whole-mount in situ hybridization for the ingluvial ganglion was performed as previously described (14). To prepare a sense or antisense probe, 53-oligomer oligonucleotides complementary or identical to CCAP precursor cDNA located between nucleotides 245 and 298 were tailed at the 3' terminus by digoxigenin (DIG)-11-deoxyuridine triphosphate using a DIG oligonucleotide tailing kit (Roche Diagnostics). Hybridization and detection were carried out according to the DIG SYSTEM protocol (Roche Diagnostics).
Immunohistochemistry
The midgut was dissected from P. americana, adult males, fixed overnight at 4 C in Bouin fluid, and embedded in paraffin from which 7-µm sections were cut. Anti-CCAP antiserum was ordered from Genemed Synthesis Inc. (South San Francisco, CA), and no cross-reactivity to prohormonal forms such as the CCAP flanked by a Gly C-terminal amidation signal and/or dibasic endoproteolytic sites at either terminus was confirmed by the manufacturer. Immunohistochemical staining was performed as previously described (15) using the anti-CCAP antiserum diluted to 1:1000. Immunoreactivity was visualized by the avidin-biotin peroxidase method with a diaminobenzidine as a chromogen (Vectastain ABC Elite kit, Vector Laboratories, Inc., Burlingame, CA). The ingluvial ganglion was dissected from animal, fixed in 4% paraformaldehyde/PBS at 4 C overnight, and further processed for whole-mount immunohistochemistry as previously described (14). The tissue was incubated with the anti-CCAP antiserum diluted to 1:300 and immunoreactivity was visualized by the avidin-biotin peroxidase method with diaminobenzidine.
Controls included 1) preabsorption of the antiserum with synthetic CCAP (Bachem AG, Bubendorf, Switzerland) at a final concentration of 105 M for overnight at 4 C and 2) deletion of the primary antiserum. No specific immunostaining was observed in either of the controls.
Measurement of
-amylase activity from the midgut
Cockroach midguts were dissected in low glucose saline [154 mM NaCl, 13 mM KCl, 10 mM CaCl2, 3 mM MgCl2, 0.01% D (+)-glucose, 1% Ficoll Type 400, and 10 mM HEPES (pH 7.0)] containing a protease inhibitor cocktail (Complete, EDTA-free, Roche Diagnostics). Isolated midguts were opened to remove food particles and peritrophic membrane. The tissues were incubated in the low glucose saline at room temperature for 30 min in the presence or absence of CCAP.
-Amylase and maltase activities released into the supernatant was quantified using the
-amylase measuring kit (Kikkoman Corp., Chiba, Japan) and Wako glucose test kit (Wako Pure Chemical Industries, Osaka, Japan), respectively.
Gut contraction assay
The foregut, midgut, and hindgut of P. americana were used for bioassays to confirm the effect of CCAP on the cockroach itself. After dissection, these tissue sections were mounted in a chamber containing insect saline of the following composition: 154 mM NaCl, 13 mM KCl, 1 mM CaCl2 and 11 mM D(+)-glucose in 10 mM HEPES (pH 7.0), and treated as previously described (12). Stimulatory effect on the contraction of the tissue sections were monitored at different concentrations of CCAP and plotted in percent of maximum contraction for each tissue.
Statistical analysis
Results are shown as the mean ± SE. Dose-response study on the midgut
-amylase and maltase activities were analyzed by the one-way ANOVA with Dunnett error protection. Differences were accepted as significant when P < 0.05.
| Results |
|---|
|
|
|---|
|
We attempted to clone the CCAP cDNA from the cockroach ventral nerve cord, given that high CCAP gene expression was detected in the ventral nerve cord of the moth, Manduca sexta (18). We initially performed an RT-PCR experiment with degenerate primers corresponding to the partial CCAP sequence PFCNAFT and the anchor primer, followed by reamplification of the first-round PCR products with degenerate primers corresponding to the partial CCAP sequence CNAFTGCG and the same anchor primer. Furthermore, 5' RACE with specific primers for the clone was employed to elucidate the full-length sequence of the CCAP cDNA. A representative sequence was submitted to the DDBJ/EMBL/GenBank databases (AB126034). As shown in Fig. 2A
, the CCAP precursor cDNA was composed of 1149 nucleotides containing a short 5' untranslated sequence of 103 bp, a single open reading frame of 513 bp, and a 3' untranslated sequence of 533 bp. The open reading frame region began with two putative start codons at positions 104 and 110 and terminated with a TAA stop codon at position 617. Four polyadenylation signals (AATAAA) were found in the 3' untranslated region at positions 935, 1013, 1028, and 1102. A single CCAP sequence, flanked by a glycine C-terminal amidation signal and dibasic endoproteolytic sites at both termini, was shown to be encoded at residue 5063 in the precursor. In addition, amino acid sequence comparisons of the cockroach CCAP precursor with those of M. sexta and Drosophila melanogaster revealed that one CCAP sequence and several amino acid residues are conserved among all precursors (Fig. 2B
), although the biological significance of such conserved amino acid residues remains unknown.
|
|
|
|
-amylase activity in the midgut
-amylase (Fig. 6A
|
|
| Discussion |
|---|
|
|
|---|
In the present study, we showed the isolation of CCAP from the midgut of P. americana, localization of the CCAP mRNA and the peptide, stimulation of
-amylase activity from midgut, and contractile effects on the alimentary tract. RT-PCR analysis (Fig. 3
) clearly demonstrates expression of the CCAP gene in the midgut as well as in the ventral cord, providing evidence that CCAP serves as both a neuropeptide and a gut peptide. Furthermore, in situ hybridization revealed that the CCAP gene was expressed exclusively in several endocrine cells within the midgut epithelium (Fig. 4A
), suggesting a biological role for CCAP as a secretory substance from midgut endocrine cells. A striking feature is that abundant CCAP immunoreactivity was detected at the lateral margins rather than the center of the endocrine cells (Fig. 4C
). In addition, a previous ultrastructural study showed exocytosis of secretory granules on the lateral and the basal surface of the midgut endocrine cell of P. americana (6). In combination, these findings strongly suggest that the CCAP produced in the midgut is released to adjacent cells as a paracrine factor and participates in the regulation of some midgut epithelial cells such as columnar cells and/or regenerative cells. In the insect midgut, columnar cells are predominantly responsible for synthesis and secretion of digestive enzymes (3). Because the midgut epithelial cells are not subject to neuronal regulation (3), synthesis and secretion of digestive enzymes and/or absorption of nutrients are expected to be stimulated not only by digests in the lumen but also by the midgut endocrine cells (4). Notably, the CCAP-expressing cells are closely associated with columnar cells (Figs. 4
, AC), and CCAP was shown to increase the activity of the midgut
-amylase (Fig. 6A
). These data are in good agreement with the fact that
-amylase-containing columnar cells were localized in the midgut epithelium of P. americana (23) and that high
-amylase activity in the midgut was also observed in the cockroaches, D. punctata (24) and Nauphoeta cinerea (25). Taken together, these findings led to the conclusion that CCAP released from the midgut endocrine cells is involved in food digestion and/or absorption via paracrine regulation of the activity of
-amylase produced and secreted by the columnar cells, although the possibility cannot be excluded that CCAP may regulates activities of other digestive enzymes than carbohydrate-degrading enzymes.
CCAP was also shown to elicit a prominent contraction of all gut muscles (Fig. 7
), suggesting that CCAP controls gut movement in the cockroach. However, an in situ hybridization signal was absent throughout the midgut circular muscle region (Fig. 4A
), revealing that the midgut muscle region is not responsible for the synthesis of CCAP. On the other hand, CCAP-immunoreactivity was observed in nerve fibers running through the midgut circular muscle (Fig. 4D
). The ingluvial ganglion, which is a major component of the stomatogastric nervous system, is known to innervate the foregut and anterior midgut (26), and CCAP production was in fact detected in the ingluvial ganglion (Fig. 5
, A and B). Moreover, the midgut epithelial CCAP is not likely to be released in the circular muscle layers, given that CCAP-immunoreactive endocrine cells are rarely observed near the circular muscle layers (Fig. 4B
). These histochemical observations indicate that CCAP present in the midgut circular muscle region is transported there from the ingluvial ganglion and then is involved in regulation of foregut and midgut contraction. In addition, CCAP mRNA was detected in the ventral cord (Fig. 3
). The cockroach abdominal ganglia of the ventral cord innervate the dorsal and ventral muscles, the dorsal heart, and the hindgut (2). The immunohistochemical and physiological studies on a variety of insects showed that CCAP from the ventral cord controls the heart beat and hindgut contraction (20, 27, 28, 29, 30), suggesting the involvement of nerve cord CCAP in the control of hindgut movement and/or the heart beat in the cockroach. This notion is compatible with the result showing cockroach hindgut contraction by CCAP (Fig. 7
, C and D). Therefore, it is presumed that CCAP participates in the regulation of feeding behavior by concerted functions as a paracrine substance for induction of carbohydrate digestion by the midgut epithelium and a myostimulatory neuropeptide for each of the gut tissues and/or hearts. Such functional relationships are now being examined.
We for the first time showed the expression of both the CCAP gene and peptide in the insect midgut endocrine cells (Figs. 3
and 4
). The CCAP gene expression has yet to be investigated in the midgut of other insects including D. melanogaster (19) and M. sexta (18). Similarly, the gene expression of other myomodulatory neuropeptides such as leucomyosuppressin (10) and tachykinin-related peptides (31) in the midgut has so far been investigated in only a single insect species. Further studies are required to establish common or species-specific biological roles for these neuropeptides as midgut factors.
Also of interest is the structure and function of a CCAP receptor. The stimulatory effects of CCAP on the midgut
-amylase activity (Fig. 6
) and contraction of the midgut (Fig. 7
, B and D) suggest the presence of a CCAP receptor in this tissue. Recently, identification of a CCAP receptor from Drosophila was reported (32). However, the low binding affinity of the receptor with CCAP implied that other receptors serve as authentic CCAP receptors. Therefore, molecular and functional characterization of the cockroach CCAP receptors is expected to contribute to the further investigation of the biological roles and modes of action for CCAP in the insect kingdom. Identification of CCAP receptor from the cockroach is currently in progress.
In conclusion, we have shown that an arthropod neuropeptide, CCAP, has multifunctional roles in the regulation of gut tissues as both a neuropeptide and a novel midgut factor.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received June 7, 2004.
Accepted for publication September 1, 2004.
| References |
|---|
|
|
|---|
-aminobutyric acid receptor subunits in the head ganglia of Periplaneta americana using an anti-RDL C-terminal antibody. Neurosci Lett 289:197200[CrossRef][Medline]
This article has been cited by other articles:
![]() |
M. Aoyama, T. Kawada, M. Fujie, K. Hotta, T. Sakai, T. Sekiguchi, K. Oka, N. Satoh, and H. Satake A Novel Biological Role of Tachykinins as an Up-Regulator of Oocyte Growth: Identification of an Evolutionary Origin of Tachykininergic Functions in the Ovary of the Ascidian, Ciona intestinalis Endocrinology, September 1, 2008; 149(9): 4346 - 4356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Chung, D. C. Wilcockson, N. Zmora, Y. Zohar, H. Dircksen, and S. G. Webster Identification and developmental expression of mRNAs encoding crustacean cardioactive peptide (CCAP) in decapod crustaceans J. Exp. Biol., October 1, 2006; 209(19): 3862 - 3872. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |